Ortin Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 5 April 2024 .Powered by Capital Market - Live News

Net loss of Ortin Laboratories reported to Rs 2.79 crore in the quarter ended December 2023 as against net profit of Rs 0.46 crore during the previous quarter ended December 2022. Sales declined 87.93% to Rs 0.14 crore in the quarter ended December 2023 as against Rs 1.16 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.141.16 -88 OPM %-1864.2954.31 - PBDT-2.750.53 PL PBT-2.810.46 PL NP-2.790.46 PL Powered by Capital Market - Live News

Ortin Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News

Ortin Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 14 December 2023 .Powered by Capital Market - Live News

Net loss of Ortin Laboratories reported to Rs 1.12 crore in the quarter ended September 2023 as against net profit of Rs 0.08 crore during the previous quarter ended September 2022. Sales declined 67.09% to Rs 0.26 crore in the quarter ended September 2023 as against Rs 0.79 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales0.260.79 -67 OPM %-342.31-27.85 - PBDT-1.04-0.31 -235 PBT-1.10-0.38 -189 NP-1.120.08 PL Powered by Capital Market - Live News